Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Recruiting × Drug Resistant Epilepsy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 106 Carcinoma, Non-Small-Cell Lung 84 Prostatic Neoplasms 52 Colorectal Neoplasms 46 Nasopharyngeal Carcinoma 42 Neoplasms 38 Stomach Neoplasms 31 Multiple Myeloma 31 Lung Neoplasms 26 Neoplasm Metastasis 24 Carcinoma, Hepatocellular 24 Leukemia, Myeloid, Acute 23 Recurrence 22 Rectal Neoplasms 21 Ovarian Neoplasms 21 Squamous Cell Carcinoma of Head and Neck 20 Uterine Cervical Neoplasms 19 Esophageal Neoplasms 19 Brain Neoplasms 19 Triple Negative Breast Neoplasms 18 Pancreatic Neoplasms 18 Small Cell Lung Carcinoma 17 Colonic Neoplasms 17 Urinary Bladder Neoplasms 15 Lymphoma, Large B-Cell, Diffuse 14 Lymphoma, Follicular 14 Endometrial Neoplasms 13 Myasthenia Gravis 12 Head and Neck Neoplasms 12 Esophageal Squamous Cell Carcinoma 12

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05534672 2023-08-08

RaRE-TS

Children's Memorial Health Institute, Poland

Phase 3 Recruiting

Drug Resistant Epilepsy, Epilepsy, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡